enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Dabrafenib - Wikipedia

    en.wikipedia.org/wiki/Dabrafenib

    Dabrafenib is indicated as a single agent for the treatment of people with unresectable or metastatic melanoma with BRAF V600E mutation. [2] Dabrafenib is indicated, in combination with trametinib, for BRAF V600E-positive unresectable or metastatic melanoma, metastatic non-small cell lung cancer, metastatic anaplastic thyroid cancer, and unresectable or metastatic solid tumors.

  3. Trametinib - Wikipedia

    en.wikipedia.org/wiki/Trametinib

    Trametinib, sold under the brand name Mekinist among others, is an anticancer medication used for the treatment of melanoma [4] [5] and glioma. [ 6 ] [ 7 ] It is a MEK inhibitor drug with anti-cancer activity. [ 8 ]

  4. ‘Stress lifted’ with son’s brain tumour drug made available ...

    www.aol.com/stress-lifted-son-brain-tumour...

    The combination of dabrafenib and trametinib was approved for NHS use for youngsters with brain tumours in April. However, Alexander has been accessing the medication privately at a cost of about ...

  5. Targeted therapy - Wikipedia

    en.wikipedia.org/wiki/Targeted_therapy

    Braf inhibitors (vemurafenib, dabrafenib, LGX818) used to treat metastatic melanoma that harbors BRAF V600E mutation; MEK inhibitors (trametinib, MEK162) are used in experiments, often in combination with BRAF inhibitors to treat melanoma; CDK inhibitors, e.g. PD-0332991, LEE011 in clinical trials; Hsp90 inhibitors, some in clinical trials

  6. Tissue-agnostic cancer drug - Wikipedia

    en.wikipedia.org/wiki/Tissue-agnostic_cancer_drug

    Dabrafenib and trametinib have been approved as tissue-agnostic drugs for solid tumors that are B-RAF positive. [ 16 ] Tissue-agnostic cancer drugs that are under development as of May 2022 [update] include Selitrectinib (Loxo-195) and anti- ERBB3 antibodies.

  7. MEK inhibitor - Wikipedia

    en.wikipedia.org/wiki/MEK_inhibitor

    Trametinib (GSK1120212), ... Also studied in combination with BRAF inhibitor dabrafenib to treat BRAF-mutated melanoma. In clinical trials. PD-325901, ...

  8. List of drugs granted breakthrough therapy designation

    en.wikipedia.org/wiki/List_of_drugs_granted...

    Dabrafenib: Dostarlimab: Eflornithine: Elranatamab: To treat relapsed or refractory multiple myeloma after at least four lines of therapy [4] Enfortumab vedotin: Iptacopan: To treat paroxysmal nocturnal hemoglobinuria [4] Ivosidenib: Lecanemab: To treat Alzheimer's disease [4] Miglustat: Nedosiran

  9. U0126 - Wikipedia

    en.wikipedia.org/wiki/U0126

    U0126 [1] [2] is the 'code' name for a compound associated with cancer treatment [3] and also in preventing ischemia and cellular oxidative stress. It also has likely utility in strokes and heart attacks. [4]